Evidence map›Paper›PMID 25691661›Full record

ArticleMolecular and cellular biology2015

Local mitochondrial-endolysosomal microfusion cleaves voltage-dependent anion channel 1 to promote survival in hypoxia.

M Christiane Brahimi-Horn, Sandra Lacas-Gervais, Ricardo Adaixo, Karine Ilc, Matthieu Rouleau, Annick Notte, Marc Dieu, Carine Michiels, Thibault Voeltzel, Véronique Maguer-Satta and 8 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Organelle contact sites in cancer cells.Cell death & disease · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 4 countries.

M Christiane Brahimi-HornInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France.
Sandra Lacas-GervaisCentre Commun de Microscopie Appliquée, University of Nice Sophia-Antipolis, Nice, France.
Ricardo AdaixoBiozentrum, University of Basel, Basel, Switzerland.
Karine IlcInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France.
Matthieu RouleauLaboratoire de PhysioMédecine Moléculaire, UMR 7370 CNRS, University of Nice Sophia-Antipolis, Faculty of Medicine, Nice, France.
Annick NotteURBC-NARILIS, University of Namur, Namur, Belgium.
Marc DieuURBC-NARILIS, University of Namur, Namur, Belgium.
Carine MichielsURBC-NARILIS, University of Namur, Namur, Belgium.
Thibault VoeltzelCentre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS U5286, Centre Léon Bérard, Lyon, France.
Véronique Maguer-SattaCentre de Recherche en Cancérologie de Lyon, INSERM U1052, CNRS U5286, Centre Léon Bérard, Lyon, France.
Joffrey PelletierInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France.
Marius IlieInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France Human Tissue Biobank Unit/CRB and Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, Nice, France.
Paul HofmanInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France Human Tissue Biobank Unit/CRB and Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, Nice, France.
Bénédicte ManouryINSERM U1013, Hôpital Necker, Paris, France.
Alexander SchmidtBiozentrum, University of Basel, Basel, Switzerland.
Sebastian HillerBiozentrum, University of Basel, Basel, Switzerland.
Jacques PouysségurInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France Centre Scientifique de Monaco (CSM), Monaco.
Nathalie M MazureInstitute for Research on Cancer and Aging of Nice, CNRS-UMR 7284-INSERM U1081, University of Nice Sophia-Antipolis, Centre Antoine Lacassagne, Nice, France Nathalie.Mazure@unice.fr.
Inserm · FRUniversity of Basel · CHUniversity of Namur · BECentre Antoine Lacassagne · FRCentre de Recherche en Cancérologie de Lyon · FRCentre Léon Bérard · FRHôpital Pasteur · FRLaboratoire de PhysioMédecine Moléculaire · FRScientific Centre of Monaco · MCUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oxygen-limiting (hypoxic) microenvironment of tumors induces metabolic reprogramming and cell survival, but the underlying mechanisms involving mitochondria remain poorly understood. We previously demonstrated that hypoxia-inducible factor 1 mediates the hyperfusion of mitochondria by inducing Bcl-2/adenovirus E1B 19-kDa interacting protein 3 and posttranslational truncation of the mitochondrial ATP transporter outer membrane voltage-dependent anion channel 1 in hypoxic cells. In addition, we showed that truncation is associated with increased resistance to drug-induced apoptosis and is indicative of increased patient chemoresistance. We now show that silencing of the tumor suppressor TP53 decreases truncation and increases drug-induced apoptosis. We also show that TP53 regulates truncation through induction of the mitochondrial protein Mieap. While we found that truncation was independent of mitophagy, we observed local microfusion between mitochondria and endolysosomes in hypoxic cells in culture and in patients' tumor tissues. Since we found that the endolysosomal asparagine endopeptidase was responsible for truncation, we propose that it is a readout of mitochondrial-endolysosomal microfusion in hypoxia. These novel findings provide the framework for a better understanding of hypoxic cell metabolism and cell survival through mitochondrial-endolysosomal microfusion regulated by hypoxia-inducible factor 1 and TP53.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAnimalsCell HypoxiaCell LineCell SurvivalHeLa CellsHep G2 CellsHumansLungLung NeoplasmsLysosomesMembrane ProteinsMiceMitochondriaProto-Oncogene ProteinsBNIP3 protein, humanMembrane ProteinsProto-Oncogene ProteinsTumor Suppressor Protein p53VDAC1 protein, humanVoltage-Dependent Anion Channel 1

Identifiers

PMID25691661
PMCPMC4387213
OpenAlexW2143261130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.